Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick F Lang

Showing results (211-220 of 251) with videos related to

Pageof 26
Sort By:
The Journal of Clinical Investigation|January 10, 2013
The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastomaBrittany C Parker, Matti J Annala, David E Cogdell, et al.
Plos One|November 10, 2011
Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomasMarta M Alonso, Ricardo Diez-Valle, Lorea Manterola, et al.
Nature Communications|March 15, 2018
Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodelingCarla Danussi, Promita Bose, Prasanna T Parthasarathy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2018
A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft ModelsPascal O Zinn, Sanjay K Singh, Aikaterini Kotrotsou, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|January 1, 2013
Existence of glioma stroma mesenchymal stemlike cells in Korean glioma specimensYoung Goo Kim, Soyoun Jeon, Ga-Yeong Sin, et al.
Genes & Development|December 23, 2011
The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant gliomaKrishna P L Bhat, Katrina L Salazar, Veerakumar Balasubramaniyan, et al.
Journal for Immunotherapy of Cancer|July 28, 2022
Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitryTeresa T Nguyen, Dong Ho Shin, Sagar Sohoni, et al.
Neuro-Oncology|January 18, 2024
Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastomaMekenzie M Peshoff, Pravesh Gupta, Shivangi Oberai, et al.
Nature Communications|February 10, 2022
Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy targetNourhan Abdelfattah, Parveen Kumar, Caiyi Wang, et al.
Neuro-Oncology|April 29, 2017
Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patientsJavier M Figueroa, Johan Skog, Johnny Akers, et al.
Pageof 26

Showing results (211-220 of 251) with videos related to

Sort By:
Pageof 26
The Journal of Clinical Investigation|January 10, 2013
The tumorigenic FGFR3-TACC3 gene fusion escapes miR-99a regulation in glioblastomaBrittany C Parker, Matti J Annala, David E Cogdell, et al.
Plos One|November 10, 2011
Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomasMarta M Alonso, Ricardo Diez-Valle, Lorea Manterola, et al.
Nature Communications|March 15, 2018
Atrx inactivation drives disease-defining phenotypes in glioma cells of origin through global epigenomic remodelingCarla Danussi, Promita Bose, Prasanna T Parthasarathy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2018
A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft ModelsPascal O Zinn, Sanjay K Singh, Aikaterini Kotrotsou, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery|January 1, 2013
Existence of glioma stroma mesenchymal stemlike cells in Korean glioma specimensYoung Goo Kim, Soyoun Jeon, Ga-Yeong Sin, et al.
Genes & Development|December 23, 2011
The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant gliomaKrishna P L Bhat, Katrina L Salazar, Veerakumar Balasubramaniyan, et al.
Journal for Immunotherapy of Cancer|July 28, 2022
Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitryTeresa T Nguyen, Dong Ho Shin, Sagar Sohoni, et al.
Neuro-Oncology|January 18, 2024
Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastomaMekenzie M Peshoff, Pravesh Gupta, Shivangi Oberai, et al.
Nature Communications|February 10, 2022
Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy targetNourhan Abdelfattah, Parveen Kumar, Caiyi Wang, et al.
Neuro-Oncology|April 29, 2017
Detection of wild-type EGFR amplification and EGFRvIII mutation in CSF-derived extracellular vesicles of glioblastoma patientsJavier M Figueroa, Johan Skog, Johnny Akers, et al.
Pageof 26